Pro-Med
Latest round
- Series B
Last raised
- Jun 2004
Total raised
- $3.6M
Investors
- 3
About Pro-Med
Founded in 1997 in Linz, Austria, Pro-Med specializes in drug delivery solutions. The founder, Enrico Armiento, has a history of innovation in healthcare technology.Pro-Med specializes in the SmartDose® On-Body Delivery System, launched in 2010. This system enables self-administration of medications, particularly for biologics, featuring advanced technologies for precise dosing and improved patient compliance.Pro-Med generates revenue primarily through B2B contracts with pharmaceutical and biotech firms. The company is working on the next generation of the SmartDose® system, with plans to enter new geographic markets by 2025, specifically targeting regions within Europe and Asia to broaden access to its innovative drug delivery solutions.
Who invested in Pro-Med
3 investors across 2 rounds
See all investors in Pro-Med
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pro-Med
Who invested in Pro-Med?
Pro-Med has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pro-Med raised?
Pro-Med has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Pro-Med last raise money?
Pro-Med's most recent round on record is a Series B, in Jun 2004.
What does Pro-Med do?
Founded in 1997 in Linz, Austria, Pro-Med specializes in drug delivery solutions.
Where is Pro-Med headquartered?
Pro-Med is headquartered in Linz, Austria.
Which VCs invest in companies like Pro-Med?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at Pro-Med's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Pro-Med? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.